That's crucial, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable. To put it simply, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (future report review). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're created to do. This was a breakthrough practically nobody saw. However it's going to have extensive implications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be lots of financial investment chances in this space, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (last year). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back perhaps substantially prior to going higher - united arab emirates. I've been covering bitcoin for a long time now. One of the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly educating readers. However that's not the huge question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. self-driving cars. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous fantastic private business on the brink of hitting the public markets And I have actually been dealing with a brand-new method for you to invest even before these business go public.
This chance has been developing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to reserve your area free of charge.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our typical beat (genetic sequencing companies jeff brown). And when it pertains to tech investing, we leave it to the professionals. The good news is, we have several such professionals in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing specialists we understand (legacy report prediction). In truth, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These patterns are experiencing rapid development and producing amazing opportunities for investors. I want to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown genome sequencing stock. However despite what many readers might believe, this is a trend that's simply starting. Although the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (biotech stocks). Losing 2 months of manufacturing and sales actually impacts the number of 5G devices are sold in the fiscal year. When you think about all of that, offering 250 million systems is amazing. More notably, the hold-ups triggered by the pandemic produced a ton of suppressed demand. Which demand is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G devices will be shipped in 2021 - tech stock. And that's not my only 5G prediction When I've talked about 5G in the past, I have actually described its three various stages.
In Phase 2, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Stage Three, 5G services start to be provided (jeff brown latest prediction). That's when we begin to see applications working on 5G networks. Think of things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase 3 by this summer season. This begins something of a virtuous cycle: Many people don't actually appreciate the innovation. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In fact, 5G is going to open a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment opportunities going forward will be enormous. Stepping away from 5G, the next crucial innovation I anticipate in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not work correctly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And during that time, there were truly only 3 companies running in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering amazing returns. This entire market is effectively a greenfield chance.
There's space for numerous companies to exist in this area. jeff brown top stock pick 2021. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its most current Alpha, Fold software application can accurately forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is essential due to the fact that the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error process. However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug therapies produced using this innovation. This was among those advancements that nearly nobody observed. But it's going to have extensive ramifications for treating disease. And, naturally, there will be a lot of financial investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly considerably before going higher. I've been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin - jeff brown biotech picks. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. jeff brown biotech stocks. Mass, Mutual is a 150-year-old organization. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info is up to date as of February 2021, but we might not independently validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to pick winning technology stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an excellent point of view on the market. He's always on the hunt for new chances, and he shares many of his best picks in the Future Report.
That's high praise, but it's not absurdly reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully forecasted a few of the most significant economic events of the previous 20 years. Although he doesn't appear to launch his choices to the general public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it best every time, however Jeff Brown's accurate forecasts have actually earned him legions of dedicated fans. That says a lot about his capability. The Near Future Report is published by Brownstone Research, a prominent financial research publisher. Brownstone Research offers numerous research services with a wide array of specializations - united states.
The business is also connected with Bonner & Partners, another well-respected research study publisher - melania trump. On its site, Brownstone states its objective is to supply retail investors with professional-grade research: "For too long, the very best financial investment research study has not been available to specific investors. It has actually been normally reserved for financial investment banks, hedge funds, personal equity, and high-net-worth clients. last year. The mission of Brownstone Research study is to make that kind of proprietary research readily available to any investors looking to acquire an edge in the marketplaces. The goal is easy to provide distinct and rewarding investment research found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also acts as the company's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of constant success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you know even a bit about the market, you understand that he has a track record as a King Midas of sorts. angel investor. Whatever he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In reality, Brown thinks S.A.V. jeff bezos. might be "the most significant trend of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding two advanced innovations: expert system and electrical cars and trucks. Musk hopes the mix will help him develop the very first fully-autonomous, self-driving automobiles ever. It's nothing except the automotive industry's Holy Grail. As you know, electric lorries and self-driving vehicle stocks have actually been substantial this year, however the Wall Street device has approved hype without much tangible outcome. In spite of a drastic increase in competitors over the past few years, Brown still believes Musk has the very best chance of putting it all together.
tech might be the magic string that ties it all together. S.A.V. represents Shared Autonomous Vehicle, and it might be the future of transportation. Basically, this technology would allow you to lease out your vehicle as an autonomous, self-driving taxi when you're not using it. You simply get out of the car and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a substantial piece of the profits. It sounds ridiculous, but it might be closed than you believe.